TY  - JOUR

T1  - Ceralasertib plus Durvalumab in Ras Mutant and Ras Wild-Type Advanced Non–Small Cell Lung Cancer: Two Cohorts of the Phase II Platform National Lung Matrix Trial

JO  - Clinical Cancer Research

UR  - https://eprints.whiterose.ac.uk/id/eprint/246766

UR  - https://doi.org/10.1158/1078-0432.ccr-26-1365

PY  - 2026/10/09

AU  - Middleton G

AU  - Buchanan R

AU  - Savage J

AU  - De La Mata Chicharro J

AU  - Mehmi M

AU  - Wilkins RJ

AU  - Kelly RDW

AU  - Wilson C

AU  - Kanhere A

AU  - Robbins HL

AU  - Ames L et al

ED  - 

DO  - DOI: 10.1158/1078-0432.ccr-26-1365

PB  - American Association for Cancer Research (AACR)

SP  - OF1

EP  - OF14

Y2  - 2026/11/05

ER  -